Navigation Links
HUYA Bioscience Announces Agreement to Provide Schering-Plough With Drug Development Candidates From China
Date:12/15/2008

Collaboration will leverage HUYA's growing Chinese bioscience network

SAN DIEGO, Dec. 15 /PRNewswire/ -- HUYA Bioscience International, a leader in US/China pharmaceutical co-development, today announced an agreement with Schering-Plough Corporation's subsidiary, N.V. Organon. Schering-Plough has selected HUYA to identify and present to Schering-Plough on an exclusive basis proprietary lead, preclinical and clinical drug candidates in specific therapeutic areas that originate in China.

"HUYA is quickly gaining a reputation as a key point of contact for members of the Chinese bioscience community looking to establish relationships with Western development partners," said Mirielle Gingras, PhD, President and CEO of HUYA. "Our agreement with Schering-Plough demonstrates both the effectiveness of our network in China, and our ability to leverage that network to benefit major development partners in the West. We are delighted to be forging this new alliance, and look forward to a fruitful collaboration."

Schering-Plough will gain access to HUYA's growing Chinese bioscience network comprising premier universities, government research institutions and bioparks throughout the country. HUYA already has agreements in place with several of these organizations whereby HUYA has ongoing exclusive access to compounds and biologics in a variety of indications. The company is currently evaluating and following the progress of more than 500 drug development candidates.

HUYA's model is based on longevity of relationships with its Chinese partners to provide a continuous source of compounds rather than a one-time single compound strategy. The ongoing exchange of expertise and data is intended to lower risk and facilitate rapid and efficient clinical development in both China and the West.

HUYA currently has two Chinese drugs undergoing preclinical development in the US - H
'/>"/>

SOURCE HUYA Bioscience International
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Pressure BioSciences, Inc. and Omni International Announce Marketing, Distribution, and Technology Development Agreement
2. YM BIOSCIENCES PROVIDES EU REGULATORY UPDATE
3. CeloNova BioSciences Commercializes CATANIA(TM) Coronary Stent With NanoThin Polyzene(R)-F in Europe and Middle East
4. DuPont Applied BioSciences Selects MBI to Collaborate on Process Development and Scale-Up for New Bio-based Product
5. Ellen McDonald Joins Regado Biosciences as Senior Vice President of Business Operations and Chief Business Officer
6. Frost & Sullivan Recognizes Martek Biosciences for Unique and Customer-Focused Strategies With Customer Value Enhancement Award
7. PURE Bioscience and Ciba Strike New Contract for Natural Antimicrobial
8. Regado Biosciences to Present at the Piper Jaffray Health Care Conference on Tuesday, December 2, 2008
9. Sangamo BioSciences to Webcast Annual Investor and Analyst Briefing and Presentation at Piper Jaffray Health Care Conference
10. Cyntellect Appoints Former BD Biosciences Executive Andre Lubarsky as Director of Sales - North America
11. Neurocrine Biosciences to Present at the 20th Annual Piper Jaffray Health Care Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... , Chemical Abstracts Ser...ion, reports that China,s patent office is now the...ications in chemistry. China trailed Japan,s paten...tion (WIPO), and the United States Patent and Trad...assed the USPTO in 2005, WIPO in 2006, and exceede...
(Date:11/23/2009)... , SALT LAKE CITY, Nov. 23, 2009 In a provocati...s that rising carbon dioxide emissions the major ...ss the world,s economy collapses or society builds...h day. , "It looks unlikely that there will be ...observed acceleration in carbon dioxide emission r...
(Date:11/23/2009)... , Quantum computing promises ultra-fast communic...pt sensitive information. But trying to use quantu...y delicate business. Now two physicists have shown... knots in quantum communication, while keeping the... current issue of Physical Review Letters and hi...
(Date:11/23/2009)... ,, INCLINEVILLAGE,Nev.,Nov.23/PRNewswire-Fi...ayannouncedthatNASDAQhasestablishedNovember27,2009...ndtostockholdersresultingfromthesecuritizationtran...paidonDecember15,2009toallstockholdersofrecordonth...atepershareamountofthedividendat$1.67pershareofcom...
Breaking Biology Technology:China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 2China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 3Is global warming unstoppable? 2Is global warming unstoppable? 3Is global warming unstoppable? 4PDL BioPharma Announces Ex-Dividend Date of November 27 for Special Dividend 2
...Albert Einstein College of Medicine researchers pu...journal -, CLINTON, N.J., Sept. 25 Producing a s...tering an experimental drug from,Ikaria (an inject...lfide),showed promise in a study designed to reduc...ed in the online edition of the Proceedings of the...
...receives $500,000 ,genius award, with ,no strings ...cell biologist at,Fred Hutchinson Cancer Research ...rthur Fellowships, a "genius" award given annually...ion. Roth will receive $500,000 over,five years of... the Hutchinson Center,s Basic Sciences Division, ...
...pt. 25 Earlier today,Signalife announced that it ...3 million (three million three hundred thousand do... of new management,s initial sales campaign. In,th...hat is $5.28 million of,sales orders of our Fideli...e Company, and -- as we fulfill our existing order...
Other Biology Technology:New Study Shows Promise for Hydrogen Sulfide in Reducing Heart-Attack Damage, Ikaria Announces 2New Study Shows Promise for Hydrogen Sulfide in Reducing Heart-Attack Damage, Ikaria Announces 3Basic Scientist Mark Roth Wins MacArthur Fellowship 2Basic Scientist Mark Roth Wins MacArthur Fellowship 3Signalife Receives Another $3.3 Million Sales Orders 2
(Date:11/24/2009)...ors to understanding how sounds associated with Na...al or if they hear it at all. , The same type o...uses to detect flaws in the space shuttle,s behemo...o peek inside the giant head of a whale. The scans... of a whale,s hearing anatomy using a breakthrough...
(Date:11/24/2009)...arkable class of ring-shaped protein motors has be...eley National Laboratory (Berkeley Lab) using a st... the Advanced Light Source (ALS). These protein mo...lication, and are vital to the survival of all bio...as the human papillomavirus, which has been linked...
(Date:11/24/2009)...ng held secrets of the earth,s history locked in i...very little information on the environments that h...of years. Now, a team of researchers from nine ins...tune of $10 million dollars by the National Scienc...gs literally. These scientists will drill through...
Breaking Biology News(10 mins):Rocket science leads to new whale discovery 2Atomic-level snapshot catches protein motor in action 2Atomic-level snapshot catches protein motor in action 3Atomic-level snapshot catches protein motor in action 4LSU gets to the bottom of things -- in Antarctica 2Research Finds New Crop of Breast Cancer Genes 47543 1Research Finds New Crop of Breast Cancer Genes 47543 2New Study Documents High Prevalence of Serious Mental Illnesses Among Nations Jail Populations 47540 1New Study Documents High Prevalence of Serious Mental Illnesses Among Nations Jail Populations 47540 2Horizon Therapeutics HZT 501 Significantly Reduces Incidence of NSAID Induced Upper Gastrointestinal Ulcers in Patients With Mild to Moderate Pain 4506 1Horizon Therapeutics HZT 501 Significantly Reduces Incidence of NSAID Induced Upper Gastrointestinal Ulcers in Patients With Mild to Moderate Pain 4506 2Horizon Therapeutics HZT 501 Significantly Reduces Incidence of NSAID Induced Upper Gastrointestinal Ulcers in Patients With Mild to Moderate Pain 4506 3Horizon Therapeutics HZT 501 Significantly Reduces Incidence of NSAID Induced Upper Gastrointestinal Ulcers in Patients With Mild to Moderate Pain 4506 4Horizon Therapeutics HZT 501 Significantly Reduces Incidence of NSAID Induced Upper Gastrointestinal Ulcers in Patients With Mild to Moderate Pain 4506 5
...anish . , A scientific group of the Universitie...nd Nakai (China), among others, have deciphered fo...ase papaya (Carica papaya), according to the cover...ure . One of the researchers is a scientist assign...rtment of Genetics of the University of Granada...
... Caramellino, two doctoral students in NJITs grad...ed recognition at a student poster event organized... manufacture nano- and micro-sized drug particles....ty for Pharmaceutical Engineering was the sponsor....has recognized that new technologies and methods m...
...Business Assessment Group will fund four faculty r...ified these one-year projects from a number of exc...tation earlier this spring. Funding for the progr...al Property Management, and is generated by royalt...rojects show a significant probability of having c...
Other Biology News:Scientists decipher fruit tree genome for the first time 2Scientists decipher fruit tree genome for the first time 3NJIT doctoral students receive recognition at poster competition 2OSU technologies funded for development 2OSU technologies funded for development 3
Amido Black 10B, CI 20470 from Research Organics, Inc.
FCS File Sanitizer from Verity Software House
Anti-FAK, phospho (Tyr576 / Tyr577) Antibody, Unconjugated from Cell Signaling Technology
Anti-Latanoprost (EIA Antiserum) Antibody, Unconjugated from Cayman Chemical
Biology Products: